Current strategies for identifying and validating targets for new treatment-shortening drugs for TB
Tools
Tools
Tools
Williams, KJ and Duncan, K (2007) Current strategies for identifying and validating targets for new treatment-shortening drugs for TB CURRENT MOLECULAR MEDICINE, 7 (3). pp. 297-307.
Full text not available from this repository.| Item Type: | Article | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Divisions : | Surrey research (other units) | |||||||||
| Authors : |
|
|||||||||
| Date : | 1 May 2007 | |||||||||
| DOI : | 10.2174/156652407780598575 | |||||||||
| Uncontrolled Keywords : | Science & Technology, Life Sciences & Biomedicine, Medicine, Research & Experimental, Research & Experimental Medicine, MEDICINE, RESEARCH & EXPERIMENTAL, tuberculosis, drug discovery, essential gene, target validation, MYCOBACTERIUM-TUBERCULOSIS H37RV, STRUCTURAL GENOMICS CONSORTIUM, GENE-EXPRESSION PROFILES, IN-VITRO, MDR-TB, NITROIMIDAZOPYRAN PA-824, CRYSTALLIZATION FACILITY, TRANSPOSON MUTAGENESIS, PULMONARY TUBERCULOSIS, CONDITIONAL EXPRESSION | |||||||||
| Related URLs : | ||||||||||
| Depositing User : | Symplectic Elements | |||||||||
| Date Deposited : | 17 May 2017 10:37 | |||||||||
| Last Modified : | 24 Jan 2020 19:41 | |||||||||
| URI: | http://epubs.surrey.ac.uk/id/eprint/828505 |
Actions (login required)
 |
View Item |
Downloads
Downloads per month over past year